We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Opinionated Science Episode 30: Psychedelics: A Trip Through Psilocybin and MDMA Research

On this week’s Opinionated Science, the team takes a look at the growing potential of psychedelic medicine.

Hundreds of new clinical trials, exciting new synthetic psychedelics and a universal acceptance that current mental health treatments are not meeting patients’ needs have pushed the mind-altering potential of psychedelics into the medical mainstream.

In this episode, Technology Networks Senior Science Writer Ruairi J Mackenzie takes a deep dive into four leading psychedelic compounds: psilocybin, MDMA, ketamine and DMT.

Read more from this podcast:

Why Does Ketamine Fight Depression? Finding Answers at BNA 2019

Mirror’s Image: Could a Simple Flip Produce a More Effective Ketamine-Based Antidepressant?

The Neuroscience of Psychedelic Drugs: Your Brain on Psilocybin With Frederick Streeter Barrett

Meet the Author
Ruairi J Mackenzie
Ruairi J Mackenzie
Senior Science Writer